C 91 Pill - yellow capsule/oblong, 18mm
Pill with imprint C 91 is Yellow, Capsule/Oblong and has been identified as Rivastigmine Tartrate 1.5 mg. It is supplied by Cadila Pharmaceuticals Limited.
Rivastigmine is used in the treatment of Parkinson's Disease; Alzheimer's Disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for C 91
Rivastigmine Tartrate
- Imprint
- C 91
- Strength
- 1.5 mg
- Color
- Yellow
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Cholinesterase inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cadila Pharmaceuticals Limited
- National Drug Code (NDC)
- 71209-0012
- Inactive Ingredients
-
hypromelloses,
microcrystalline cellulose,
silicon dioxide,
magnesium stearate,
gelatin,
titanium dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
Related images for "C 91"
More about rivastigmine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (38)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: cholinesterase inhibitors
Patient resources
- Rivastigmine drug information
- Rivastigmine transdermal
- Rivastigmine (Oral) (Advanced Reading)
- Rivastigmine (Transdermal) (Advanced Reading)
- Rivastigmine Capsules
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.